Thrombosis Clinical Trials

159 recruitingLast updated: June 17, 2026

There are 159 actively recruiting thrombosis clinical trials across 39 countries. Studies span Not Applicable, Phase 4, Phase 2, Phase 3, Early Phase 1, Phase 1. Top locations include Beijing, Beijing Municipality, China, Cleveland, Ohio, United States, Columbus, Ohio, United States. Updated daily from ClinicalTrials.gov.


Thrombosis Trials at a Glance

159 actively recruiting trials for thrombosis are listed on ClinicalTrialsFinder across 6 cities in 39 countries. The largest study group is Not Applicable with 38 trials, with the heaviest enrollment activity in Beijing, Cleveland, and Columbus. Lead sponsors running thrombosis studies include Inari Medical, Kafrelsheikh University, and Ottawa Hospital Research Institute.

Browse thrombosis trials by phase

Treatments under study

About Thrombosis Clinical Trials

Looking for clinical trials for Thrombosis? There are currently 38 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Thrombosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Thrombosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 159 trials

Recruiting

Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking

Deep Vein Thrombosis (DVT)Venous EmbolismThrombus in the Peripheral Venous Vasculature+1 more
Argon Medical Devices185 enrolled4 locationsNCT07102160
Recruiting

Cancer-related Venous Thromboembolic Disease - Cohort Study

CancerThromboses, VenousThrombosis Embolism
University Hospital, Brest150 enrolled1 locationNCT06393764
Recruiting

Thrombectomy in PE

Pulmonary Embolism and Thrombosis
University Hospital Plymouth NHS Trust2,000 enrolled1 locationNCT07650435
Recruiting

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

Peripheral Arterial DiseaseDVTAcute Limb Ischemia+8 more
Medtronic Endovascular50 enrolled2 locationsNCT07335341
Recruiting
Phase 2Phase 3

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

Deep Venous Thrombosis
Yale University258 enrolled22 locationsNCT04924322
Recruiting

Cerebral Venous Thrombosis Cohort Study in China Mainland

Cerebral Venous Sinus ThrombosisDeep Cerebral Vein ThrombosisCortical Vein Thrombosis
Capital Medical University3,000 enrolled1 locationNCT03919305
Recruiting
Not Applicable

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

Deep Venous ThrombosisVenous ThromboembolismPost Thrombotic Syndrome
Inari Medical300 enrolled64 locationsNCT05701917
Recruiting

RevCore for In Stent Thrombosis

In-stent Thrombosis
Inari Medical100 enrolled16 locationsNCT06394739
Recruiting

ClotTriever® Thrombectomy System Use-Result Survey in Japan

Deep Vein Thrombosis
Inari Medical100 enrolled13 locationsNCT06871683
Recruiting

Comparison Of Different Mechanical Thrombectomy Devices in Endovascular Treatment of Acute Iliofemoral Venous Thrombosis

Deep Vein Thrombosis
RenJi Hospital180 enrolled1 locationNCT07622212
Recruiting

Changes in Regional Ventilation-Perfusion Match Following Percutaneous Transluminal Angioplasty for Arteriovenous Graft Thrombosis

End Stage Renal Disease on DialysisArteriovenous Graft Thrombosis
First Affiliated Hospital of Wannan Medical College20 enrolled1 locationNCT07613632
Recruiting
Phase 3

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

Cancer-Associated Thrombosis (CAT)
Regeneron Pharmaceuticals1,120 enrolled12 locationsNCT07410117
Recruiting

Machine Learning for Diagnosis of Occlusive MI in LBBB Patients

Myocardial InfarctionChest PainLeft Bundle-Branch Block+2 more
Konya City Hospital50 enrolled1 locationNCT07620119
Recruiting
Not Applicable

Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease

ThrombosisAmputationPlatelet Aggregation Inhibitors+4 more
Massachusetts General Hospital484 enrolled2 locationsNCT07613840
Recruiting
Phase 4

Pharmaco Mechanical Thrombolysis Associated With Anticoagulation Compared With Anticoagulation in the Acute Phase of Very Symptomatic Proximal Venous Thrombosis of the Lower Limbs.

Iliofemoral Venous Thrombosis
Nantes University Hospital228 enrolled1 locationNCT06472518
Recruiting
Phase 4

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Cardiovascular DiseasesVenous ThromboembolismPulmonary Embolism+6 more
Drahomir Aujesky276 enrolled40 locationsNCT04263038
Recruiting
Not Applicable

Effects of Different Tunnel Methods in PICC Catheterization

PICC Line PlacementPICC-associated Thrombosis
Sun Yat-sen University284 enrolled1 locationNCT07594704
Recruiting

Translational Immunodiagnostics in Stroke (TrImS)

Atrial FibrillationAcute Ischemic StrokeCardioembolic Stroke+9 more
The University of Hong Kong650 enrolled1 locationNCT05300997
Recruiting

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants

ThrombosisAntiphospholipid SyndromeAnticoagulants Causing Adverse Effects in Therapeutic Use
Stéphane Zuily500 enrolled1 locationNCT04262492
Recruiting
Not Applicable

Assessment of Pulmonary Perfusion and Hemodynamic Measurements by Electrical Impedance Tomography in Patients Undergoing Pulmonary Thromboendarterectomy.

Pulmonary Embolism and ThrombosisPulmonary Thromboendarterectomy
University of Sao Paulo General Hospital36 enrolled1 locationNCT07577700